Skip to main content
Top

Open Access 25-04-2025 | Pyelonephritis | Review Article–Urology

Contrast-enhanced ultrasound in the evaluation and management of solid renal lesions based on EFSUMB guidelines

Authors: Laura Eusebi, Federica Masino, Michele Bertolotto, Manuela Montatore, Giuseppe Sortino, Lucia Pitoni, Stefano Santarelli, Andrea Benedetto Galosi, Giuseppe Guglielmi

Published in: Journal of Medical Ultrasonics

Login to get access

Abstract

Contrast-enhanced ultrasound (CEUS) has become an important tool for the detection and characterization of solid renal lesions, complementing traditional B-mode US, which often struggles to distinguish between solid and cystic masses. CEUS enhances diagnostic accuracy by providing detailed vascularization information, helping to identify potentially malignant solid lesions and differentiate between pseudotumours and solid masses. Moreover, CEUS employs a contrast agent that is safe even for nephropathic patients and can be used without concern for kidney function, making it an advantageous method for renal imaging. In this narrative review, following the European Federation of Societies for Ultrasound in Medicine and Biology guidelines, the authors show its main indications: characterizing indeterminate renal lesions in patients with transplanted kidney, monitoring non-surgical lesions, diagnosing inflammatory-infectious renal pathologies, and assessing advanced renal lesions and masses in the surgical bed.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Contrast-enhanced ultrasound in the evaluation and management of solid renal lesions based on EFSUMB guidelines
Authors
Laura Eusebi
Federica Masino
Michele Bertolotto
Manuela Montatore
Giuseppe Sortino
Lucia Pitoni
Stefano Santarelli
Andrea Benedetto Galosi
Giuseppe Guglielmi
Publication date
25-04-2025
Publisher
Springer Nature Singapore
Published in
Journal of Medical Ultrasonics
Print ISSN: 1346-4523
Electronic ISSN: 1613-2254
DOI
https://doi.org/10.1007/s10396-025-01546-z

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest